Protocol Section
The Protocol Section is one of the main sections in ClinicalTrials.gov data structure. It contains protocol-related information for clinical trials, including identification, status, design, eligibility, and other key details about how the trial is structured and conducted.
Protocol Section path is as follows:
Study -> Protocol Section -> Protocol Modules (Identification, Status, Design, Eligibility, etc.)
Protocol Section
Ignite Creation Date:
2025-12-24 @ 5:19 PM
Ignite Modification Date:
2025-12-24 @ 5:19 PM
NCT ID:
NCT03315650
Description:
An intermediate report summarizing the baseline data will be provided to Bayer (financial support).
A final report summarizing baseline and follow-up data will be provided to ethical committees in Germany, to governmental authority, and to Bayer.
Participating clinics will receive benchmarking reports (comparison of their own data with those of all other sites).
Data will be made accessible to participating investigators for publication in journals and on conferences.
Study:
NCT03315650
Study Brief:
Rivaroxaban in Patients With Atrial Fibrillation Undergoing PCI